The Nordic Molecular Tumour Board is an independent, academic collaboration between health care professionals and academics in the Nordic countries (Iceland, Finland, Sweden, Norway and Denmark) with an interest in early phase oncology trials. NMTB organises monthly meetings.
The next NMTB meeting will be on Thursday March 27 15:30 - 16:30 (CEST) on teams. Please log-in to the member site to see the agenda (if you dont have a user please contact gfageren@ous-hf.no).
On 26 September 2025, the first founding meeting of the Nordic Molecular Tumour Board took place, bringing together representatives from molecular tumour board and clinical trial units in Denmark, Norway, Sweden, Finland, and Iceland.